Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry

Clinica Chimica Acta

Volumn 414, Issue , 2012, Pages 135-141

  Guo, Yumei ^a   Wang, Xianmin ^b   Qiu, Ling ^c   Qin, Xuzhen ^c   Liu, Hui ^a   Wang, Yanying ^a   Li, Fang ^a   Wang, Xiaodong ^a   Chen, Guoqiang ^a   Song, Gaoguang ^a   Li, Fenjie ^a   Guo, Shuai ^a   Li, Zhili ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b Heze Municipical Hospital   (China)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Direct infusion ESI FTICR MS; Lung cancer; PLS DA; Serum metabolites; Sex; Staging

Indexed keywords

BIOLOGICAL MARKER; CARNITINE; LIPID; LYSOPHOSPHATIDYLCHOLINE; OLEAMIDE; SPHINGOMYELIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENDER; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METABOLITE; MIDDLE AGED; POSITIVE ION ELECTROSPRAY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; BLOOD; CYCLOTRON; DISCRIMINANT ANALYSIS; FOURIER ANALYSIS; LUNG TUMOR; MASS SPECTROMETRY; METABOLISM;

CYCLOTRONS; DISCRIMINANT ANALYSIS; FEMALE; FOURIER ANALYSIS; HUMANS; LUNG NEOPLASMS; LYSOPHOSPHATIDYLCHOLINES; MALE; MASS SPECTROMETRY; MIDDLE AGED; SPHINGOMYELINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866496952     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.08.010     Document Type: Article

References (45)

1. Hocker, J.R., Peyton, M.D., Lerner, M.R., et al. Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry. Lung Cancer 74 (2011), 206–211.
2. Imran, S., Jon, A., Cancer of the lung: staging, radiology, surgery. Surgery 29 (2011), 221–226.
3. Bowen, B.P., Northen, T.R., Dealing with the unknown: metabolomics and metabolite atlases. J Am Soc Mass Spectrom 21 (2010), 1471–1476.
4. Nikkila, J., Sysi-Aho, M., Ermolov, A., et al. Gender-dependent progression of systemic metabolic states in early childhood. Mol Syst Biol, 4, 2008, 197.
5. Oresic, M., Metabolomics, a novel tool for studies of nutrition, metabolism and lipid dysfunction. Nutr Metab Cardiovasc Dis 19 (2009), 816–824.
6. Tan, Y., Yin, P., Tang, L., et al. Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis. Mol Cell Proteomics, 11, 2012 M111 010694.
7. Lv, W., Yang, T., Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis. Clin Biochem 45 (2012), 127–133.
8. Nishiumi, S., Shinohara, M., Ikada, A., et al. Serum metabolomics as a novel diagnostic approach for pancreatic cancer. Metabolomics 6 (2010), 518–528.
9. Huang, Z., Lin, L., Gao, Y., et al. Bladder cancer determination via two urinary metabolites: a biomarker pattern approach. Mol Cell Proteomics, 10, 2011 M111 007922.
10. Sutphen, R., Xu, Y., Wilbanks, G.D., et al. Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiol Biomarkers Prev 13 (2004), 1185–1191.
11. Kochhar, S., Jacobs, D.M., Ramadan, Z., Berruex, F., Fuerholz, A., Fay, L.B., Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. Anal Biochem 352 (2006), 274–281.
12. Basant, A., Rege, M., Sharma, S., Sonawat, H.M., Alterations in urine, serum and brain metabolomic profiles exhibit sexual dimorphism during malaria disease progression. Malar J, 9, 2010, 110.
13. Bertram, H.C., Duus, J.O., Petersen, B.O., et al. Nuclear magnetic resonance-based metabonomics reveals strong sex effect on plasma metabolism in 17-year-old Scandinavians and correlation to retrospective infant plasma parameters. Metabolism 58 (2009), 1039–1045.
14. Donington, J.S., Colson, Y.L., Sex and gender differences in non-small cell lung cancer. Semin Thorac Cardiovasc Surg 23 (2011), 137–145.
15. Hori, S., Nishiumi, S., Kobayashi, K., et al. A metabolomic approach to lung cancer. Lung Cancer 74 (2011), 284–292.
16. Takahashi, H., Kai, K., Shinbo, Y., et al. Metabolomics approach for determining growth-specific metabolites based on Fourier transform ion cyclotron resonance mass spectrometry. Anal Bioanal Chem 391 (2008), 2769–2782.
17. Ohta, D., Kanaya, S., Suzuki, H., Application of Fourier-transform ion cyclotron resonance mass spectrometry to metabolic profiling and metabolite identification. Curr Opin Biotechnol 21 (2010), 35–44.
18. Han, J., Danell, R.M., Patel, J.R., et al. Towards high-throughput metabolomics using ultrahigh-field Fourier transform ion cyclotron resonance mass spectrometry. Metabolomics 4 (2008), 128–140.
19. Yang, H.J., Park, K.H., Lim, D.W., Kim, H.S., Kim, J., Analysis of cancer cell lipids using matrix-assisted laser desorption/ionization 15-T Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun Mass Spectrom 26 (2012), 621–630.
20. Lokhov, P.G., Kharybin, O.N., Archakov, A.I., Diagnosis of lung cancer based on direct-infusion electrospray mass spectrometry of blood plasma metabolites. Int J Mass Spectrom 309 (2012), 200–205.
21. Rizzarelli, P., Zampino, D., Ferreri, L., Impallomeni, G., Direct electrospray ionization mass spectrometry quantitative analysis of sebacic and terephthalic acids in biodegradable polymers. Anal Chem 83 (2011), 654–660.
22. Yang, Y., Kameoka, J., Wachs, T., Henion, J.D., Craighead, H.G., Quantitative mass spectrometric determination of methylphenidate concentration in urine using an electrospray ionization source integrated with a polymer microchip. Anal Chem 76 (2004), 2568–2574.
23. Wachs, T., Henion, J., A device for automated direct sampling and quantitation from solid-phase sorbent extraction cards by electrospray tandem mass spectrometry. Anal Chem 75 (2003), 1769–1775.
24. Polson, C., Sarkar, P., Incledon, B., Raguvaran, V., Grant, R., Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography–tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 785 (2003), 263–275.
25. Zhao, Z., Xu, Y., An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples. J Lipid Res 51 (2010), 652–659.
26. Gasperino, J., Rom, W.N., Gender and lung cancer. Clin Lung Cancer 5 (2004), 353–359.
27. Kiyohara, C., Ohno, Y., Sex differences in lung cancer susceptibility: a review. Gend Med 7 (2010), 381–401.
28. Hsu, L.H., Chu, N.M., Liu, C.C., et al. Sex-associated differences in non-small cell lung cancer in the new sera: is gender an independent prognostic factor?. Lung Cancer 66 (2009), 262–267.
29. Jacobs-Lawson, J.M., Schumacher, M.M., Hughes, T., Arnold, S., Gender differences in psychosocial responses to lung cancer. Gend Med 7 (2010), 137–148.
30. Belani, C.P., Marts, S., Schiller, J., Socinski, M.A., Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer 55 (2007), 15–23.
31. Vashist, P., Zakalik, D., Howard, G., Wong, C.O., Investigating gender specific metabolic differences in non-small cell lung cancer by F-18 FDG PET.2007 ASCO Annual Meeting Proceedings Part I. J Clin Oncol, 25, 2007, 7663.
32. Noga, A.A., Vance, D.E., A gender-specific role for phosphatidylethanolamine N-methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very low density lipoproteins in mice. J Biol Chem 278 (2003), 21851–21859.
33. Postle, A.D., Henderson, N.G., Koster, G., Clark, H.W., Hunt, A.N., Analysis of lung surfactant phosphatidylcholine metabolism in transgenic mice using stable isotopes. Chem Phys Lipids 164 (2011), 549–555.
34. Vance, D.E., Walkey, C.J., Cui, Z., Phosphatidylethanolamine N-methyltransferase from liver. Biochim Biophys Acta 1348 (1997), 142–150.
35. Dong, J., Cai, X., Zhao, L., et al. Lysophosphatidylcholine profiling of plasma: discrimination of isomers and discovery of lung cancer biomarkers. Metabolomics 6 (2010), 478–488.
36. Carrola, J., Rocha, C.M., Barros, A.S., et al. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J Proteome Res 10 (2011), 221–230.
37. Rocha, C.M., Carrola, J., Barros, A.S., et al. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma. J Proteome Res 10 (2011), 4314–4324.
38. Fujita, Y., Yoshizumi, M., Izawa, Y., et al. Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation. Endocrinology 147 (2006), 1377–1385.
39. Linkous, A.G., Yazlovitskaya, E.M., Hallahan, D.E., Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis. J Natl Cancer Inst 102 (2010), 1398–1412.
40. Ogretmen, B., Sphingolipids in cancer: regulation of pathogenesis and therapy. FEBS Lett 580 (2006), 5467–5476.
41. Segui, B., Andrieu-Abadie, N., Jaffrezou, J.P., Benoist, H., Levade, T., Sphingolipids as modulators of cancer cell death: potential therapeutic targets. Biochim Biophys Acta 1758 (2006), 2104–2120.
42. Lee, G.K., Lee, H.S., Park, Y.S., et al. Lipid MALDI profile classifies non-small cell lung cancers according to the histologic type. Lung Cancer 76 (2012), 197–203.
43. Song, H., Peng, J.S., Yao, D.S., et al. Metabolic disorders of fatty acids and fatty acid amides associated with human gastric cancer morbidity. Chin Med J (Engl) 125 (2012), 757–763.
44. Ong ES, Zou L, Li S, Cheah PY, Eu KW, Ong CN. Metabolic profiling in colorectal cancer reveals signature metabolic shifts during tumorigenesis. Mol Cell Proteomics in press. http://dx.doi.org/10.1074/mcp.M900551-MCP200 (http://www.mcponline.org/content/early/recent).
45. Chen, T., Xie, G., Wang, X., et al. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics, 10, 2011 M110 004945.